(1) “Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) (ACT)”. The purpose of this clinical trial is to compare the efficacy of twice daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback